封面
市場調查報告書
商品編碼
1375932

無引線起搏製造商市場規模、佔有率和趨勢分析報告:按起搏室、最終用途、地區、細分市場趨勢,2023-2030 年

Leadless Pacemakers Market Size, Share & Trends Analysis Report By Pacing Chamber (Single Chamber, Dual Chamber), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

無引線 S​​pacemaker 市場成長與趨勢:

Grand View Research 的一份新報告顯示,到 2030 年,全球無引線太空船市場預計將達到 17.4 億美元。

預計2023年至2030年該市場將以15.7%的年複合成長率成長。市場的成長歸因於技術進步、心臟病盛行率上升以及對微創手術的偏好。此外,世界人口高齡化正在推動對無引線起搏器的需求,因為心搏過緩在老化人口中更為常見。據克利夫蘭診所稱,老年人口中約有 50 萬人出現心搏過緩症狀,這正在推動無引線起搏器產業的成長。

無線或無引線起搏器經常用於成年患者,但正如《循環》雜誌上發表的一項研究發現,對於心搏過緩的兒童患者來說,無線或無引線起搏器可以是一種安全有效的臨時替代。這是可能的:這些是《心律不整和電生理學》雜誌上發表的一項研究的結果,美國心臟協會附屬雜誌。這一市場開拓預計將成為市場成長的潛在驅動力。

此外,公司不斷增加對無引線空間製造商的業務舉措正在支持行業成長。 2021年7月,微創科學公司就C輪資金籌措簽署了最終協議。此次資金籌措成功吸引總投資1.5億美元。此外,這筆資金籌措的主要目標之一是到 2027 年至 2028 年開發無引線太空船並將其商業化。

無引線起搏器市場報告亮點

  • 按地區分類,北美佔據市場主導地位,2022 年收益佔有率為 50.71%。這種成長是由於心臟病患者數量的增加、聯邦法規機構產品核可的增加、技術進步以及手術可用性的增加。
  • 在起搏室方面,單室細分市場佔據主導地位,2022年銷售佔有率為67.40%。單腔無引線節律器適用於多種心搏過緩或心臟傳導阻滯的患者。
  • 按最終用途分類,醫院業佔據市場主導地位,2022 年銷售佔有率為 89.0%。這一佔有率歸因於先進基礎設施、研究合作和夥伴關係以及臨床試驗的可用性。

目錄

第1章 調查方法與範圍

第2章 執行摘要

第3章 無引線心律調節器市場變數、趨勢和範圍

  • 市場體系展望
  • 市場趨勢及展望
  • 市場動態
  • 營商環境分析

第4章 無引線心律調節器市場:心律調節室業務分析

  • 無引線起搏器市場:起搏室運動和市場佔有率分析,2022 年和 2030 年
  • 單室
  • 雙室

第5章 無引線太空船市場:最終用途業務分析

  • 無引線太空船市場:2022 年和 2030 年最終用途趨勢和市場佔有率分析
  • 醫院
  • 門診設施

第6章 無引線太空船市場:區域業務分析

  • 區域市場簡介
  • 2022 年按國家/地區分類的市場佔有率分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第7章 競爭形勢

  • 公司分類
  • 策略規劃
  • 公司簡介/名單
    • Abbott
    • Medtronic
Product Code: GVR-4-68040-138-6

Leadless Pacemakers Market Growth & Trends:

The global leadless pacemakers market size is anticipated to reach USD 1.74 billion by 2030, based on a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 15.7% from 2023 to 2030. The growth of the market is attributed to technological advancements, rising prevalence of heart diseases, and preference for minimally invasive procedures. Moreover, the growing aging population globally propels the demand for leadless pacemakers, as bradycardia is common in the geriatric population. According to the Cleveland Clinic, approximately half a million of the geriatric population show symptoms of bradycardia, thereby driving the growth in the leadless pacemakers industry.

Wireless or leadless pacemakers, frequently used in adult patients, have emerged as a potentially safe and efficient temporary alternative for children experiencing bradycardia, as revealed by research featured in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal affiliated with the American Heart Association. This development is expected to be a potential driver for the growth of the market.

In addition, growing business initiatives by the companies for leadless pacemakers propels the industry growth. In July 2021, MicroPort Scientific Corporation concluded definitive agreements related to its Series C financing round. The financing has successfully garnered a total investment of USD 150 million. Moreover, one of the key objectives of this funding is to develop and commercialize its leadless pacemakers by 2027 - 2028.

Leadless Pacemakers Market Report Highlights:

  • In terms of region, North America dominated the market in 2022 with a revenue share of 50.71%. This growth can be attributed to the increasing number of heart patients, growing product approvals from federal regulatory bodies, technological advancements, and ease of accessibility of the procedure
  • In terms of pacing chamber, the single chamber segment dominated the market in 2022 with a revenue share of 67.40%. Single-chamber leadless pacemakers are suitable for a broader range of patients with bradycardia or heart block.
  • In terms of end-use, the hospitals segment dominated the market in 2022 with a revenue share of 89.0%. This share is attributed to the availability of advanced infrastructure, collaborations and partnerships, and clinical trials

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Volume Price Analysis
      • 1.5.1.1. Approach 1: Volume Price Analysis
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Leadless Pacemakers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Rising prevalence of cardiovascular diseases
      • 3.3.1.2. Favorable reimbursement policies
      • 3.3.1.3. Growing adoption of leadless pacemaker instead of traditional pacemaker due to clinical safety.
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Limited manufacturers in the marketplace
  • 3.4. Business Environment Analysis
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Leadless Pacemakers Market: Pacing Chamber Business Analysis

  • 4.1. Leadless Pacemakers Market: Pacing Chambers Movement & Market Share Analysis, 2022 & 2030
  • 4.2. Single Chamber
    • 4.2.1. Single Chamber Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Dual Chamber
    • 4.3.1. Dual Chamber Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Leadless Pacemakers Market: End-use Business Analysis

  • 5.1. Leadless Pacemakers Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 5.2. Hospitals
    • 5.2.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Outpatient Facilities
    • 5.3.1. Outpatient Facilities Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Leadless Pacemakers Market: Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. Market Share Analysis by Country, 2022
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. Asia Pacific
    • 6.2.4. Latin America
    • 6.2.5. MEA
  • 6.3. North America
    • 6.3.1. North America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Regulatory Framework
    • 6.3.3. Canada
      • 6.3.3.1. Canada Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Regulatory Framework
  • 6.4. Europe
    • 6.4.1. Europe Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Germany Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Regulatory Framework
    • 6.4.3. UK
      • 6.4.3.1. UK Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Regulatory Framework
    • 6.4.4. France
      • 6.4.4.1. France Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
    • 6.4.5. Italy
      • 6.4.5.1. Italy Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Regulatory Framework
    • 6.4.6. Spain
      • 6.4.6.1. Spain Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Regulatory Framework
    • 6.4.7. Denmark
      • 6.4.7.1. Denmark Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Regulatory Framework
    • 6.4.8. Sweden
      • 6.4.8.1. Sweden Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.8.2. Key Country Dynamics
      • 6.4.8.3. Competitive Scenario
      • 6.4.8.4. Regulatory Framework
    • 6.4.9. Norway
      • 6.4.9.1. Norway Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.9.2. Key Country Dynamics
      • 6.4.9.3. Competitive Scenario
      • 6.4.9.4. Regulatory Framework
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Regulatory Framework
    • 6.5.3. China
      • 6.5.3.1. China Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Regulatory Framework
    • 6.5.4. India
      • 6.5.4.1. India Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Regulatory Framework
    • 6.5.5. South Korea
      • 6.5.5.1. South Korea Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.5.2. Key Country Dynamics
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Regulatory Framework
    • 6.5.6. Australia
      • 6.5.6.1. Australia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.6.2. Key Country Dynamics
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Regulatory Framework
    • 6.5.7. Thailand
      • 6.5.7.1. Thailand Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.7.2. Key Country Dynamics
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Regulatory Framework
  • 6.6. Latin America
    • 6.6.1. Latin America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Regulatory Framework
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Regulatory Framework
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Regulatory Framework
  • 6.7. MEA
    • 6.7.1. MEA Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. South Africa Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.2.2. Key Country Dynamics
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Regulatory Framework
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Saudi Arabia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.3.2. Key Country Dynamics
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Regulatory Framework
    • 6.7.4. UAE
      • 6.7.4.1. UAE Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.4.2. Key Country Dynamics
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Regulatory Framework
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.5.2. Key Country Dynamics
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. Regulatory Framework

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Profiles/Listing
    • 7.3.1. Abbott
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Medtronic
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives

List of Tables

  • Table 1. List of Abbreviations
  • Table 2. List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Leadless pacemakers market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Leadless Pacemakers Market: Pacing Chamber Outlook Key Takeaways
  • Fig. 15 Leadless Pacemakers Market: Pacing Chamber Movement Analysis
  • Fig. 16 Single Chamber Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Dual Chamber Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Leadless Pacemakers Market: End-use Outlook Key Takeaways
  • Fig. 19 Leadless Pacemakers Market: End-use Movement Analysis
  • Fig. 20 Hospitals Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Outpatient Facilities Market Estimates and Forecast Market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional Marketplace: Key Takeaways
  • Fig. 23 Regional outlook, 2022 & 2030
  • Fig. 24 Global Leadless Pacemakers Market: Region Movement Analysis
  • Fig. 25 North America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 30 UK Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 31 France Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 38 Japan Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 39 China Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 40 India Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 41 Australia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 51 Kuwait Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Leadless Pacemakers Market, 2018 - 2030 (USD Million)